Avita Medical | 1811094D - Debt


Avita Medical reported AUD46.05M in Debt for its fiscal semester ending in December of 2025.





Debt Change Date
Accuray USD 170.24M 4.52M Sep/2024
Celltrion KRW 160.58B 733.3M Mar/2026
Clinuvel Pharmaceuticals AUD 879.78K 189.09K Jun/2024
Cochlear AUD 235.7M 10.9M Jun/2025
CSL USD 11.96B 219M Dec/2024
Cspc Pharmaceutical CNY 641.11M 146.11M Dec/2025
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.36M 79K Mar/2026
Divis Laboratories Ltd INR 70M 30M Mar/2026
Kangmei Pharma CNY 173.71M 42.08M Mar/2026
Knight Therapeutics CAD 77.91M 28.33M Dec/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 100K 0 Dec/2023
Mayne Pharma AUD 38.82M 2.24M Jun/2024
Medical Developments International AUD 1.99M 152K Jun/2025
Nanosonics AUD 7.69M 1.49M Jun/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organigram Holdings CAD 8.2M 554K Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Pacific Edge NZD 2.9M 425K Mar/2025
Pharma Mar EUR 45.84M 1.7M Jun/2026
Polynovo AUD 15.38M 49K Jun/2024
PYC Therapeutics AUD 1.02M 185.07K Jun/2025
Qiagen NV USD 1.65B 165.82M Mar/2026
Ramsay Health Care AUD 12.12B 864.4M Jun/2025
ResMed USD 843.17M 3.18M Mar/2026
Sartorius EUR 4.05B 248.8M Jun/2026
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Telix Pharmaceuticals AUD 467.11M 48.85M Dec/2025
Tilray USD 640.95M 35.17M Jun/2022
Zealand Pharma A/S 414M 8.23M Mar/2026
Zz Pientze Pharmaceu CNY 1.07B 2.82M Mar/2026